These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31977235)

  • 21. Impact of biobanks on research outcomes in rare diseases: a systematic review.
    Garcia M; Downs J; Russell A; Wang W
    Orphanet J Rare Dis; 2018 Nov; 13(1):202. PubMed ID: 30419920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "It's all about trust": reflections of researchers on the complexity and controversy surrounding biobanking in South Africa.
    Moodley K; Singh S
    BMC Med Ethics; 2016 Oct; 17(1):57. PubMed ID: 27724893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The endothelium, a key actor in organ development and hPSC-derived organoid vascularization.
    Vargas-Valderrama A; Messina A; Mitjavila-Garcia MT; Guenou H
    J Biomed Sci; 2020 May; 27(1):67. PubMed ID: 32443983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain Organoids: Expanding Our Understanding of Human Development and Disease.
    Chuye LB; Dimitri A; Desai A; Handelmann C; Bae Y; Johari P; Jornet JM; Klejbor I; Stachowiak MK; Stachowiak EK
    Results Probl Cell Differ; 2018; 66():183-206. PubMed ID: 30209660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advantages and Potential Benefits of Using Organoids in Nanotoxicology.
    Nikonorova VG; Chrishtop VV; Mironov VA; Prilepskii AY
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular self-assembly and biomaterials-based organoid models of development and diseases.
    Shah SB; Singh A
    Acta Biomater; 2017 Apr; 53():29-45. PubMed ID: 28159716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Organoids: Tools for Understanding Biology and Treating Diseases.
    Schutgens F; Clevers H
    Annu Rev Pathol; 2020 Jan; 15():211-234. PubMed ID: 31550983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community engagement in US biobanking: multiplicity of meaning and method.
    Haldeman KM; Cadigan RJ; Davis A; Goldenberg A; Henderson GE; Lassiter D; Reavely E
    Public Health Genomics; 2014; 17(2):84-94. PubMed ID: 24556734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translational applications of adult stem cell-derived organoids.
    Drost J; Clevers H
    Development; 2017 Mar; 144(6):968-975. PubMed ID: 28292843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EngageUC: Developing an Efficient and Ethical Approach to Biobanking Research at the University of California.
    Garrett SB; Koenig BA; Brown A; Hult JR; Boyd EA; Dry S; Dohan D;
    Clin Transl Sci; 2015 Aug; 8(4):362-6. PubMed ID: 25581047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benchmarking pluripotent stem cell-derived organoid models.
    De Los Angeles A; Tunbridge EM
    Exp Neurol; 2020 Aug; 330():113333. PubMed ID: 32353463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.
    Somiari SB; Somiari RI
    Adv Exp Med Biol; 2015; 864():11-27. PubMed ID: 26420610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective derivation of a living organoid biobank of colorectal cancer patients.
    van de Wetering M; Francies HE; Francis JM; Bounova G; Iorio F; Pronk A; van Houdt W; van Gorp J; Taylor-Weiner A; Kester L; McLaren-Douglas A; Blokker J; Jaksani S; Bartfeld S; Volckman R; van Sluis P; Li VS; Seepo S; Sekhar Pedamallu C; Cibulskis K; Carter SL; McKenna A; Lawrence MS; Lichtenstein L; Stewart C; Koster J; Versteeg R; van Oudenaarden A; Saez-Rodriguez J; Vries RG; Getz G; Wessels L; Stratton MR; McDermott U; Meyerson M; Garnett MJ; Clevers H
    Cell; 2015 May; 161(4):933-45. PubMed ID: 25957691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organoids: An intermediate modeling platform in precision oncology.
    Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
    Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer modeling meets human organoid technology.
    Tuveson D; Clevers H
    Science; 2019 Jun; 364(6444):952-955. PubMed ID: 31171691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Japanese Biobanks: Current Status, Problems, and Future Challenges].
    Sueoka E
    Rinsho Byori; 2017 Feb; 65(2):190-198. PubMed ID: 30762986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recommendations on the ethical aspects of specimen collections and human biobanks for biomedical research purposes].
    Abascal Alonso M; de Abajo Iglesias FJ; Campos Castelló J; Feito Grande L; Herrera Carranza J; Júdez Gutiérrez J; Martín Arribas MC; Martín UA; Pàmpols Ros T; Sánchez Martínez MJ; Terracini B;
    Rev Esp Salud Publica; 2007; 81(2):95-111. PubMed ID: 17639679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer research using organoid technology.
    Kretzschmar K
    J Mol Med (Berl); 2021 Apr; 99(4):501-515. PubMed ID: 33057820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.
    Palechor-Ceron N; Krawczyk E; Dakic A; Simic V; Yuan H; Blancato J; Wang W; Hubbard F; Zheng YL; Dan H; Strome S; Cullen K; Davidson B; Deeken JF; Choudhury S; Ahn PH; Agarwal S; Zhou X; Schlegel R; Furth PA; Pan CX; Liu X
    Cells; 2019 Oct; 8(11):. PubMed ID: 31717887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.